Cardiff Park Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Cardiff Park Advisors's LLY Position: Q1 2026 in Review
Cardiff Park Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $14.2K and bringing the position to 835 shares worth $768K. The position accounts for 0.06% of the portfolio, ranked #141.
Cardiff Park Advisors first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $882K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Cardiff Park Advisors held 835 shares of Eli Lilly worth $768K as of Q1 2026.
- Cardiff Park Advisors bought 14 Eli Lilly shares in Q1 2026, an estimated $14.2K.
- Eli Lilly made up 0.06% of Cardiff Park Advisors's portfolio in Q1 2026, its #141 holding.
- Cardiff Park Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
- Cardiff Park Advisors's Eli Lilly position peaked at $882K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.